Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.


All newly qualified pharmacists will automatically become independent prescribers upon registration from September 2026. This will lead to an estimated 2,600 pharmacists joining the NHS as independent prescribers.

Webb explained community pharmacies were valued members of the NHS and saw their role developing in the near future.

“Pharmacists and pharmacy technicians have a key role to play in helping frail, vulnerable and complex patients through primary care,” Webb told delegates at the Sigma Conference in Baku, Azerbaijan.

“Building on government's intention to launch a community pharmacy prescribing service, the independent prescribing pathfinder programme is developing a framework for community pharmacy clinical services with independent prescribing for NHS patients.”

Last month, pharmacy minister Stephen Kinnock announced that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

He emphasised that the programme’s learning will focus on five key domains: clinical; digital; governance and safety; people; and funding and contracts.

Currently, a small number of independent prescribing pharmacists are working in community pharmacy in England. However, NHS England has yet to commission national clinical services that allow them to issue NHS prescriptions.

Webb insisted he was excited about the future of community pharmacy despite the current “uncertainties and pressures” the sector faces.

He revealed that the government’s 10 Year Health Plan and Spending Review are likely to be published next month and he anticipated announcements concerning community pharmacy.

“The plan will set out a vision and strategy for the NHS as a whole, and that includes community pharmacy,” he said.

“We won't know what's in the plan until it's published, but nevertheless, I'd like to share with you some scene setting thoughts from my own perspective - these are not based on any particular knowledge of things at the moment.

“Pharmacy and medicines optimisation are critical elements in the shift from hospital to community, from treatment to prevention and from analogue to digital.

“Pharmacy expertise is absolutely essential in all NHS teams across all sectors and pharmacists and pharmacy technicians are highly skilled professionals, respected by the public, who are ready to make a profound contribution to achieving the vision of the 10 Year Health Plan in terms of prevention, long term condition management, patient safety, elective recovery and much more.”

Webb also praised the contributions of pharmacy technicians, describing them as practitioners in their own right.

“I'm particularly pleased with the response we've had to the community pharmacy technician apprenticeship program and to announce that we will be supporting another 525 learners this year, which will launch shortly, and developing the role of pharmacy technician,” he said.

“Technicians, as practitioners in their own right, enable pharmacists across primary care to move into mainstream, independent prescribing to support workforce challenge. It's important we move together on the development of both professionals.”

More For You

Lung Cancer

Serplulimab helps immune cells recognise and destroy cancer cells more effectively.

iStock

Serplulimab gets MHRA approval for treating small cell lung cancer

The monoclonal antibody Serplulimab has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat adults with extensive-stage small cell lung cancer.

This cancer develops in the airways of the lungs and spreads fast within the lungs and other parts of the body.

Keep ReadingShow less
FCI scanner developed in Aberdeen aims to detect glioblastoma more safely than MRI scans

The Field Cycling Imaging scanner developed at the University of Aberdeen will provide more precise images than MRI scans

iStock

New scanner could improve brain tumour treatment

A new type of scanner shows promise in generating never-before-seen brain tumour images and is expected to help in treatment of glioblastoma patients.

The Field Cycling Imaging (FCI) scanner developed at the University of Aberdeen will provide more precise images than MRI scans.

Keep ReadingShow less
St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less